The global market for Pet Ectoparasiticide was valued at US$ 1602 million in the year 2024 and is projected to reach a revised size of US$ 2379 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Pet Ectoparasiticide Market

Pet ectoparasiticides are chemical or biological formulations designed to prevent, control, or eliminate external parasites such as fleas, ticks, mites, lice, and mosquitoes on companion animals like dogs and cats. These products work through contact or systemic action, disrupting parasite nerve function, reproduction, or metabolism. They are available in various dosage forms—topical solutions, oral tablets, sprays, shampoos, collars, and injectables—and play a key role in veterinary health for preventing zoonotic diseases, improving pet hygiene, and enhancing animal welfare.

The upstream segment includes suppliers of active pharmaceutical ingredients (APIs), excipients, emulsifiers, stabilizers, and packaging materials such as vials, sachets, and collars. The midstream segment encompasses pharmaceutical and veterinary companies that formulate, compound, and package ectoparasiticide products through chemical synthesis or biological extraction processes. Downstream segments consist of veterinary hospitals, clinics, distributors, and retailers that deliver products to pet owners. Supporting sectors include R&D laboratories developing novel compounds and regulatory authorities ensuring safety compliance under frameworks like EPA, EMA, and FDA. Data analytics and IoT-driven pet healthcare solutions are enhancing downstream marketing and treatment personalization.

Several veterinary pharmaceutical companies are expanding ectoparasiticide R&D and production facilities across the U.S., Europe, and Asia-Pacific. Projects include new pipeline developments in long-acting oral tablets and biodegradable flea collars. Emerging biotech startups are working on natural, plant-based, and nanoformulated ectoparasiticides for improved safety. Collaborative programs between academia and pharmaceutical firms are targeting resistance management and green synthesis technologies. Expansion plans in India and China focus on large-scale API production and global distribution to meet rising demand for pet care in developing urban markets.

2024 Global Market Average Gross Profit Margin: 42%.

North American market for Pet Ectoparasiticide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pet Ectoparasiticide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Pet Ectoparasiticide in Dogs is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Pet Ectoparasiticide include Bayer, MSD Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Zoetis, Inc., Sanofi, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals Plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Pet Ectoparasiticide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Ectoparasiticide.

The Pet Ectoparasiticide market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Ectoparasiticide market comprehensively. Regional market sizes, concerning products by Type, by Application, by Active Ingredient and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pet Ectoparasiticide companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pet Ectoparasiticide Market Report

Report Metric	Details
Report Name	Pet Ectoparasiticide Market
Accounted market size in year	US$ 1602 million
Forecasted market size in 2031	US$ 2379 million
CAGR	6.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Spot-On Liquids Oral Chewable Tablets Sprays Collars
Segment by Active Ingredient	Fipronil-based Imidacloprid-based Permethrin-based Isoxazoline-class
Segment by Mode of Action	Contact Ectoparasiticides Systemic Ectoparasiticides Natural/Biological Ectoparasiticides
Segment by Distribution Channel	Veterinary Clinics Pet Specialty Stores Online Retail/E-Commerce Pharmacy Chains
Segment by Application	Dogs Cats Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, MSD Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Zoetis, Inc., Sanofi, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals Plc, Advance Properties OOD/Huvepharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Active Ingredient etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Ectoparasiticide company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pet Ectoparasiticide Market growing?

Ans: The Pet Ectoparasiticide Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Pet Ectoparasiticide Market size in 2031?

Ans: The Pet Ectoparasiticide Market size in 2031 will be US$ 2379 million.

Who are the main players in the Pet Ectoparasiticide Market report?

Ans: The main players in the Pet Ectoparasiticide Market are Bayer, MSD Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Zoetis, Inc., Sanofi, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals Plc, Advance Properties OOD/Huvepharma

What are the Application segmentation covered in the Pet Ectoparasiticide Market report?

Ans: The Applications covered in the Pet Ectoparasiticide Market report are Dogs, Cats, Others

What are the Type segmentation covered in the Pet Ectoparasiticide Market report?

Ans: The Types covered in the Pet Ectoparasiticide Market report are Spot-On Liquids, Oral Chewable Tablets, Sprays, Collars

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pet Ectoparasiticide Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Spot-On Liquids

1.2.3 Oral Chewable Tablets

1.2.4 Sprays

1.2.5 Collars

1.3 Market by Active Ingredient

1.3.1 Global Pet Ectoparasiticide Market Size Growth Rate by Active Ingredient: 2020 VS 2024 VS 2031

1.3.2 Fipronil-based

1.3.3 Imidacloprid-based

1.3.4 Permethrin-based

1.3.5 Isoxazoline-class

1.4 Market by Mode of Action

1.4.1 Global Pet Ectoparasiticide Market Size Growth Rate by Mode of Action: 2020 VS 2024 VS 2031

1.4.2 Contact Ectoparasiticides

1.4.3 Systemic Ectoparasiticides

1.4.4 Natural/Biological Ectoparasiticides

1.5 Market by Distribution Channel

1.5.1 Global Pet Ectoparasiticide Market Size Growth Rate by Distribution Channel: 2020 VS 2024 VS 2031

1.5.2 Veterinary Clinics

1.5.3 Pet Specialty Stores

1.5.4 Online Retail/E-Commerce

1.5.5 Pharmacy Chains

1.6 Market by Application

1.6.1 Global Pet Ectoparasiticide Market Growth by Application: 2020 VS 2024 VS 2031

1.6.2 Dogs

1.6.3 Cats

1.6.4 Others

1.7 Assumptions and Limitations

1.8 Study Objectives

1.9 Years Considered

2 Global Growth Trends

2.1 Global Pet Ectoparasiticide Market Perspective (2020-2031)

2.2 Global Pet Ectoparasiticide Growth Trends by Region

2.2.1 Global Pet Ectoparasiticide Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pet Ectoparasiticide Historic Market Size by Region (2020-2025)

2.2.3 Pet Ectoparasiticide Forecasted Market Size by Region (2026-2031)

2.3 Pet Ectoparasiticide Market Dynamics

2.3.1 Pet Ectoparasiticide Industry Trends

2.3.2 Pet Ectoparasiticide Market Drivers

2.3.3 Pet Ectoparasiticide Market Challenges

2.3.4 Pet Ectoparasiticide Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pet Ectoparasiticide Players by Revenue

3.1.1 Global Top Pet Ectoparasiticide Players by Revenue (2020-2025)

3.1.2 Global Pet Ectoparasiticide Revenue Market Share by Players (2020-2025)

3.2 Global Top Pet Ectoparasiticide Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pet Ectoparasiticide Revenue

3.4 Global Pet Ectoparasiticide Market Concentration Ratio

3.4.1 Global Pet Ectoparasiticide Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pet Ectoparasiticide Revenue in 2024

3.5 Global Key Players of Pet Ectoparasiticide Head office and Area Served

3.6 Global Key Players of Pet Ectoparasiticide, Product and Application

3.7 Global Key Players of Pet Ectoparasiticide, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pet Ectoparasiticide Breakdown Data by Type

4.1 Global Pet Ectoparasiticide Historic Market Size by Type (2020-2025)

4.2 Global Pet Ectoparasiticide Forecasted Market Size by Type (2026-2031)

5 Pet Ectoparasiticide Breakdown Data by Application

5.1 Global Pet Ectoparasiticide Historic Market Size by Application (2020-2025)

5.2 Global Pet Ectoparasiticide Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pet Ectoparasiticide Market Size (2020-2031)

6.2 North America Pet Ectoparasiticide Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pet Ectoparasiticide Market Size by Country (2020-2025)

6.4 North America Pet Ectoparasiticide Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pet Ectoparasiticide Market Size (2020-2031)

7.2 Europe Pet Ectoparasiticide Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pet Ectoparasiticide Market Size by Country (2020-2025)

7.4 Europe Pet Ectoparasiticide Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Pet Ectoparasiticide Market Size (2020-2031)

8.2 Asia-Pacific Pet Ectoparasiticide Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pet Ectoparasiticide Market Size by Region (2020-2025)

8.4 Asia-Pacific Pet Ectoparasiticide Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Pet Ectoparasiticide Market Size (2020-2031)

9.2 Latin America Pet Ectoparasiticide Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pet Ectoparasiticide Market Size by Country (2020-2025)

9.4 Latin America Pet Ectoparasiticide Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pet Ectoparasiticide Market Size (2020-2031)

10.2 Middle East & Africa Pet Ectoparasiticide Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pet Ectoparasiticide Market Size by Country (2020-2025)

10.4 Middle East & Africa Pet Ectoparasiticide Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Pet Ectoparasiticide Introduction

11.1.4 Bayer Revenue in Pet Ectoparasiticide Business (2020-2025)

11.1.5 Bayer Recent Development

11.2 MSD Animal Health

11.2.1 MSD Animal Health Company Details

11.2.2 MSD Animal Health Business Overview

11.2.3 MSD Animal Health Pet Ectoparasiticide Introduction

11.2.4 MSD Animal Health Revenue in Pet Ectoparasiticide Business (2020-2025)

11.2.5 MSD Animal Health Recent Development

11.3 Boehringer Ingelheim

11.3.1 Boehringer Ingelheim Company Details

11.3.2 Boehringer Ingelheim Business Overview

11.3.3 Boehringer Ingelheim Pet Ectoparasiticide Introduction

11.3.4 Boehringer Ingelheim Revenue in Pet Ectoparasiticide Business (2020-2025)

11.3.5 Boehringer Ingelheim Recent Development

11.4 Ceva Sante Animale

11.4.1 Ceva Sante Animale Company Details

11.4.2 Ceva Sante Animale Business Overview

11.4.3 Ceva Sante Animale Pet Ectoparasiticide Introduction

11.4.4 Ceva Sante Animale Revenue in Pet Ectoparasiticide Business (2020-2025)

11.4.5 Ceva Sante Animale Recent Development

11.5 Elanco

11.5.1 Elanco Company Details

11.5.2 Elanco Business Overview

11.5.3 Elanco Pet Ectoparasiticide Introduction

11.5.4 Elanco Revenue in Pet Ectoparasiticide Business (2020-2025)

11.5.5 Elanco Recent Development

11.6 Zoetis, Inc.

11.6.1 Zoetis, Inc. Company Details

11.6.2 Zoetis, Inc. Business Overview

11.6.3 Zoetis, Inc. Pet Ectoparasiticide Introduction

11.6.4 Zoetis, Inc. Revenue in Pet Ectoparasiticide Business (2020-2025)

11.6.5 Zoetis, Inc. Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Pet Ectoparasiticide Introduction

11.7.4 Sanofi Revenue in Pet Ectoparasiticide Business (2020-2025)

11.7.5 Sanofi Recent Development

11.8 Virbac

11.8.1 Virbac Company Details

11.8.2 Virbac Business Overview

11.8.3 Virbac Pet Ectoparasiticide Introduction

11.8.4 Virbac Revenue in Pet Ectoparasiticide Business (2020-2025)

11.8.5 Virbac Recent Development

11.9 Vetoquinol S.A.

11.9.1 Vetoquinol S.A. Company Details

11.9.2 Vetoquinol S.A. Business Overview

11.9.3 Vetoquinol S.A. Pet Ectoparasiticide Introduction

11.9.4 Vetoquinol S.A. Revenue in Pet Ectoparasiticide Business (2020-2025)

11.9.5 Vetoquinol S.A. Recent Development

11.10 Dechra Pharmaceuticals Plc

11.10.1 Dechra Pharmaceuticals Plc Company Details

11.10.2 Dechra Pharmaceuticals Plc Business Overview

11.10.3 Dechra Pharmaceuticals Plc Pet Ectoparasiticide Introduction

11.10.4 Dechra Pharmaceuticals Plc Revenue in Pet Ectoparasiticide Business (2020-2025)

11.10.5 Dechra Pharmaceuticals Plc Recent Development

11.11 Advance Properties OOD/Huvepharma

11.11.1 Advance Properties OOD/Huvepharma Company Details

11.11.2 Advance Properties OOD/Huvepharma Business Overview

11.11.3 Advance Properties OOD/Huvepharma Pet Ectoparasiticide Introduction

11.11.4 Advance Properties OOD/Huvepharma Revenue in Pet Ectoparasiticide Business (2020-2025)

11.11.5 Advance Properties OOD/Huvepharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Dechra Pharmaceuticals Plc

Advance Properties OOD/Huvepharma

List of Tables

Table 1. Global Pet Ectoparasiticide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Spot-On Liquids

Table 3. Key Players of Oral Chewable Tablets

Table 4. Key Players of Sprays

Table 5. Key Players of Collars

Table 6. Global Pet Ectoparasiticide Market Size Growth Rate by Active Ingredient (US$ Million): 2020 VS 2024 VS 2031

Table 7. Key Players of Fipronil-based

Table 8. Key Players of Imidacloprid-based

Table 9. Key Players of Permethrin-based

Table 10. Key Players of Isoxazoline-class

Table 11. Global Pet Ectoparasiticide Market Size Growth Rate by Mode of Action (US$ Million): 2020 VS 2024 VS 2031

Table 12. Key Players of Contact Ectoparasiticides

Table 13. Key Players of Systemic Ectoparasiticides

Table 14. Key Players of Natural/Biological Ectoparasiticides

Table 15. Global Pet Ectoparasiticide Market Size Growth Rate by Distribution Channel (US$ Million): 2020 VS 2024 VS 2031

Table 16. Key Players of Veterinary Clinics

Table 17. Key Players of Pet Specialty Stores

Table 18. Key Players of Online Retail/E-Commerce

Table 19. Key Players of Pharmacy Chains

Table 20. Global Pet Ectoparasiticide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 21. Global Pet Ectoparasiticide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 22. Global Pet Ectoparasiticide Market Size by Region (2020-2025) & (US$ Million)

Table 23. Global Pet Ectoparasiticide Market Share by Region (2020-2025)

Table 24. Global Pet Ectoparasiticide Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 25. Global Pet Ectoparasiticide Market Share by Region (2026-2031)

Table 26. Pet Ectoparasiticide Market Trends

Table 27. Pet Ectoparasiticide Market Drivers

Table 28. Pet Ectoparasiticide Market Challenges

Table 29. Pet Ectoparasiticide Market Restraints

Table 30. Global Pet Ectoparasiticide Revenue by Players (2020-2025) & (US$ Million)

Table 31. Global Pet Ectoparasiticide Market Share by Players (2020-2025)

Table 32. Global Top Pet Ectoparasiticide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Ectoparasiticide as of 2024)

Table 33. Ranking of Global Top Pet Ectoparasiticide Companies by Revenue (US$ Million) in 2024

Table 34. Global 5 Largest Players Market Share by Pet Ectoparasiticide Revenue (CR5 and HHI) & (2020-2025)

Table 35. Global Key Players of Pet Ectoparasiticide, Headquarters and Area Served

Table 36. Global Key Players of Pet Ectoparasiticide, Product and Application

Table 37. Global Key Players of Pet Ectoparasiticide, Date of Enter into This Industry

Table 38. Mergers & Acquisitions, Expansion Plans

Table 39. Global Pet Ectoparasiticide Market Size by Type (2020-2025) & (US$ Million)

Table 40. Global Pet Ectoparasiticide Revenue Market Share by Type (2020-2025)

Table 41. Global Pet Ectoparasiticide Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 42. Global Pet Ectoparasiticide Revenue Market Share by Type (2026-2031)

Table 43. Global Pet Ectoparasiticide Market Size by Application (2020-2025) & (US$ Million)

Table 44. Global Pet Ectoparasiticide Revenue Market Share by Application (2020-2025)

Table 45. Global Pet Ectoparasiticide Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 46. Global Pet Ectoparasiticide Revenue Market Share by Application (2026-2031)

Table 47. North America Pet Ectoparasiticide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. North America Pet Ectoparasiticide Market Size by Country (2020-2025) & (US$ Million)

Table 49. North America Pet Ectoparasiticide Market Size by Country (2026-2031) & (US$ Million)

Table 50. Europe Pet Ectoparasiticide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 51. Europe Pet Ectoparasiticide Market Size by Country (2020-2025) & (US$ Million)

Table 52. Europe Pet Ectoparasiticide Market Size by Country (2026-2031) & (US$ Million)

Table 53. Asia-Pacific Pet Ectoparasiticide Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 54. Asia-Pacific Pet Ectoparasiticide Market Size by Region (2020-2025) & (US$ Million)

Table 55. Asia-Pacific Pet Ectoparasiticide Market Size by Region (2026-2031) & (US$ Million)

Table 56. Latin America Pet Ectoparasiticide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 57. Latin America Pet Ectoparasiticide Market Size by Country (2020-2025) & (US$ Million)

Table 58. Latin America Pet Ectoparasiticide Market Size by Country (2026-2031) & (US$ Million)

Table 59. Middle East & Africa Pet Ectoparasiticide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 60. Middle East & Africa Pet Ectoparasiticide Market Size by Country (2020-2025) & (US$ Million)

Table 61. Middle East & Africa Pet Ectoparasiticide Market Size by Country (2026-2031) & (US$ Million)

Table 62. Bayer Company Details

Table 63. Bayer Business Overview

Table 64. Bayer Pet Ectoparasiticide Product

Table 65. Bayer Revenue in Pet Ectoparasiticide Business (2020-2025) & (US$ Million)

Table 66. Bayer Recent Development

Table 67. MSD Animal Health Company Details

Table 68. MSD Animal Health Business Overview

Table 69. MSD Animal Health Pet Ectoparasiticide Product

Table 70. MSD Animal Health Revenue in Pet Ectoparasiticide Business (2020-2025) & (US$ Million)

Table 71. MSD Animal Health Recent Development

Table 72. Boehringer Ingelheim Company Details

Table 73. Boehringer Ingelheim Business Overview

Table 74. Boehringer Ingelheim Pet Ectoparasiticide Product

Table 75. Boehringer Ingelheim Revenue in Pet Ectoparasiticide Business (2020-2025) & (US$ Million)

Table 76. Boehringer Ingelheim Recent Development

Table 77. Ceva Sante Animale Company Details

Table 78. Ceva Sante Animale Business Overview

Table 79. Ceva Sante Animale Pet Ectoparasiticide Product

Table 80. Ceva Sante Animale Revenue in Pet Ectoparasiticide Business (2020-2025) & (US$ Million)

Table 81. Ceva Sante Animale Recent Development

Table 82. Elanco Company Details

Table 83. Elanco Business Overview

Table 84. Elanco Pet Ectoparasiticide Product

Table 85. Elanco Revenue in Pet Ectoparasiticide Business (2020-2025) & (US$ Million)

Table 86. Elanco Recent Development

Table 87. Zoetis, Inc. Company Details

Table 88. Zoetis, Inc. Business Overview

Table 89. Zoetis, Inc. Pet Ectoparasiticide Product

Table 90. Zoetis, Inc. Revenue in Pet Ectoparasiticide Business (2020-2025) & (US$ Million)

Table 91. Zoetis, Inc. Recent Development

Table 92. Sanofi Company Details

Table 93. Sanofi Business Overview

Table 94. Sanofi Pet Ectoparasiticide Product

Table 95. Sanofi Revenue in Pet Ectoparasiticide Business (2020-2025) & (US$ Million)

Table 96. Sanofi Recent Development

Table 97. Virbac Company Details

Table 98. Virbac Business Overview

Table 99. Virbac Pet Ectoparasiticide Product

Table 100. Virbac Revenue in Pet Ectoparasiticide Business (2020-2025) & (US$ Million)

Table 101. Virbac Recent Development

Table 102. Vetoquinol S.A. Company Details

Table 103. Vetoquinol S.A. Business Overview

Table 104. Vetoquinol S.A. Pet Ectoparasiticide Product

Table 105. Vetoquinol S.A. Revenue in Pet Ectoparasiticide Business (2020-2025) & (US$ Million)

Table 106. Vetoquinol S.A. Recent Development

Table 107. Dechra Pharmaceuticals Plc Company Details

Table 108. Dechra Pharmaceuticals Plc Business Overview

Table 109. Dechra Pharmaceuticals Plc Pet Ectoparasiticide Product

Table 110. Dechra Pharmaceuticals Plc Revenue in Pet Ectoparasiticide Business (2020-2025) & (US$ Million)

Table 111. Dechra Pharmaceuticals Plc Recent Development

Table 112. Advance Properties OOD/Huvepharma Company Details

Table 113. Advance Properties OOD/Huvepharma Business Overview

Table 114. Advance Properties OOD/Huvepharma Pet Ectoparasiticide Product

Table 115. Advance Properties OOD/Huvepharma Revenue in Pet Ectoparasiticide Business (2020-2025) & (US$ Million)

Table 116. Advance Properties OOD/Huvepharma Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Pet Ectoparasiticide Picture

Figure 2. Global Pet Ectoparasiticide Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pet Ectoparasiticide Market Share by Type: 2024 VS 2031

Figure 4. Spot-On Liquids Features

Figure 5. Oral Chewable Tablets Features

Figure 6. Sprays Features

Figure 7. Collars Features

Figure 8. Global Pet Ectoparasiticide Market Size Comparison by Active Ingredient (2020-2031) & (US$ Million)

Figure 9. Fipronil-based Features

Figure 10. Imidacloprid-based Features

Figure 11. Permethrin-based Features

Figure 12. Isoxazoline-class Features

Figure 13. Global Pet Ectoparasiticide Market Size Comparison by Mode of Action (2020-2031) & (US$ Million)

Figure 14. Contact Ectoparasiticides Features

Figure 15. Systemic Ectoparasiticides Features

Figure 16. Natural/Biological Ectoparasiticides Features

Figure 17. Global Pet Ectoparasiticide Market Size Comparison by Distribution Channel (2020-2031) & (US$ Million)

Figure 18. Veterinary Clinics Features

Figure 19. Pet Specialty Stores Features

Figure 20. Online Retail/E-Commerce Features

Figure 21. Pharmacy Chains Features

Figure 22. Global Pet Ectoparasiticide Market Size by Application (2020-2031) & (US$ Million)

Figure 23. Global Pet Ectoparasiticide Market Share by Application: 2024 VS 2031

Figure 24. Dogs Case Studies

Figure 25. Cats Case Studies

Figure 26. Others Case Studies

Figure 27. Pet Ectoparasiticide Report Years Considered

Figure 28. Global Pet Ectoparasiticide Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 29. Global Pet Ectoparasiticide Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 30. Global Pet Ectoparasiticide Market Share by Region: 2024 VS 2031

Figure 31. Global Pet Ectoparasiticide Market Share by Players in 2024

Figure 32. Global Pet Ectoparasiticide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 33. The Top 10 and 5 Players Market Share by Pet Ectoparasiticide Revenue in 2024

Figure 34. North America Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. North America Pet Ectoparasiticide Market Share by Country (2020-2031)

Figure 36. United States Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Canada Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Europe Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Europe Pet Ectoparasiticide Market Share by Country (2020-2031)

Figure 40. Germany Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. France Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. U.K. Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Italy Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Russia Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Ireland Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Asia-Pacific Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Asia-Pacific Pet Ectoparasiticide Market Share by Region (2020-2031)

Figure 48. China Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Japan Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. South Korea Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Southeast Asia Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. India Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Australia & New Zealand Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Latin America Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Latin America Pet Ectoparasiticide Market Share by Country (2020-2031)

Figure 56. Mexico Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Brazil Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. Middle East & Africa Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 59. Middle East & Africa Pet Ectoparasiticide Market Share by Country (2020-2031)

Figure 60. Israel Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 61. Saudi Arabia Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 62. UAE Pet Ectoparasiticide Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 63. Bayer Revenue Growth Rate in Pet Ectoparasiticide Business (2020-2025)

Figure 64. MSD Animal Health Revenue Growth Rate in Pet Ectoparasiticide Business (2020-2025)

Figure 65. Boehringer Ingelheim Revenue Growth Rate in Pet Ectoparasiticide Business (2020-2025)

Figure 66. Ceva Sante Animale Revenue Growth Rate in Pet Ectoparasiticide Business (2020-2025)

Figure 67. Elanco Revenue Growth Rate in Pet Ectoparasiticide Business (2020-2025)

Figure 68. Zoetis, Inc. Revenue Growth Rate in Pet Ectoparasiticide Business (2020-2025)

Figure 69. Sanofi Revenue Growth Rate in Pet Ectoparasiticide Business (2020-2025)

Figure 70. Virbac Revenue Growth Rate in Pet Ectoparasiticide Business (2020-2025)

Figure 71. Vetoquinol S.A. Revenue Growth Rate in Pet Ectoparasiticide Business (2020-2025)

Figure 72. Dechra Pharmaceuticals Plc Revenue Growth Rate in Pet Ectoparasiticide Business (2020-2025)

Figure 73. Advance Properties OOD/Huvepharma Revenue Growth Rate in Pet Ectoparasiticide Business (2020-2025)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions